New and resolved drug shortages with the affected strengths and expected resolution dates, manufacturer allocation and discontinuation notices, FDA import and compounding allowances, therapeutic alternative guidance, pharmacy chain stock and transfer policy changes, and price spikes on shortage drugs, with the drug and the status first.